SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-134703
Filing Date
2016-07-28
Accepted
2016-07-28 06:01:57
Documents
70
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a16-11612_110q.htm 10-Q 1394951
2 EX-10.1 a16-11612_1ex10d1.htm EX-10.1 27822
3 EX-31.1 a16-11612_1ex31d1.htm EX-31.1 13600
4 EX-31.2 a16-11612_1ex31d2.htm EX-31.2 13337
5 EX-32.1 a16-11612_1ex32d1.htm EX-32.1 7359
6 EX-32.2 a16-11612_1ex32d2.htm EX-32.2 7357
  Complete submission text file 0001104659-16-134703.txt   7029139

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT uthr-20160630.xml EX-101.INS 1751037
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20160630.xsd EX-101.SCH 49640
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20160630_cal.xml EX-101.CAL 69300
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20160630_def.xml EX-101.DEF 204232
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT uthr-20160630_lab.xml EX-101.LAB 496719
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20160630_pre.xml EX-101.PRE 349178
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 161788194
SIC: 2834 Pharmaceutical Preparations